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ARTICLES
THE HUMAN GENOME PROJECT-PROMISE AND
PROBLEMS
The Honourable Justice Michael Kirby AC CMG* t
I. SCIENCE, LAW AND ETHICS: UNRULY COMPANIONS
I suppose it was inevitable that Margaret Somerville would become a
leading figure in bioethics. She now holds professorships in both the
Faculty of Medicine and the Faculty of Law of McGill University in Mon-
treal, Quebec, Canada. Her leadership role is acknowledged by her work
in many national and international bodies, by her writing, and by her in-
defatigable participation in many important international conferences.
Yet it might have been quite different. Margaret Somerville began life
in the beautiful and orderly city of Adelaide, South Australia. The prov-
ince of South Australia always had a particular ethos amongst the colo-
nies and now, within the Australian Commonwealth. South Australia was
founded by free settlers, without the help of convicts. Many German free
thinkers took refuge there from religious and other persecution. The
province still has a strong intellectual tradition and a non-conformist con-
cern about ethics and practical morality. In 1942, Margaret Somerville
was born into this world of order and diligence. Her first chosen academic
discipline was pharmacy. She was graduated with distinction from the
University of Adelaide. She then moved to Sydney and received a Bach-
elor of Laws degree with first class honours and university medal from
* President of the Court of Appeal of New South Wales. Chairman of the Executive
Committee of the International Commission of Jurists. I acknowledge the assistance of
materials provided by Dr. G. Sutherland of the Women's and Children's Hospital, Ade-
laide, Dr. A. Reisner of the Australian National Genomic Information Service, Sydney and
Professor Don Chalmers of the University of Tasmania Law School.
Adapted from the Australian and New Zealand Association for the Advancement of
Science (ANZAAS) Public Lecture, 1993, delivered by the author at Curtin University of
Technology, Perth, Western Australia on 29 September 1993.
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the University of Sydney. From the start, therefore, her life witnessed the
interaction of science and law.
Professor Somerville proceeded to postgraduate research in Canada af-
ter a few years of legal practice in Sydney. It was natural, in light of her
background, that she should soon become immersed in doctoral study
and law reform activities concerning the interaction of law, science, and
ethics. From this work, appointment to her present posts followed with
apparent ease and inevitability. She has been honoured many times in
international and national bodies. It was my privilege, as Chancellor of
Macquarie University in Sydney, to confer upon her an honourary degree
of Doctor of Laws and in 1989, she was admitted to the Order of Austra-
lia which honours distinguished Australians.
My most recent opportunity to work with Margaret Somerville was at
an interesting conference in Bilbao, Spain, sponsored by the BBV Foun-
dation, a major research institute established by one of Spain's largest
banks. This was, in fact, the third such conference organized by the BBV
Foundation on this subject in five years. The first, in 1988, explored sci-
entific issues. The second, in 1990, examined ethical questions. This con-
ference, in 1993, examined the legal implications of genomic research,
including cross-cultural and cross-disciplinary issues of the coming
millennium.
Owing to her sharp mind, eloquent expression, and ready wit, Margaret
Somerville emerged as a leader of a most distinguished group of confer-
ence attendees, which included two Nobel laureates. At the close of the
conference, Professor Somerville was chosen to speak for the group in
summing up the complex issues discussed.
Accordingly, when I was invited to make this contribution to a collec-
tion of essays in honour of Margaret Somerville, it seemed fitting to
choose to present some of the key thoughts which emerged from that
BBV Foundation meeting. I do not pretend that this essay will cover the
entire landscape of the legal issues emerging from the Human Genome
Project. But it will give those lawyers who, like me, venture upon this
territory in comparative ignorance, a broad picture of the Project and
some of the many legal problems which it brings in its train.
II. THE PAST IS WrrHIN Us
Let me begin my exploration of this theme with another famous Aus-
tralian who, like Margaret Somerville, is one of my heroes. I refer to the
late Kath Walker, who reverted to her Aboriginal name: Oodgeroo of
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the Noonuccal Tribe. Upon. her too, I conferred an honourary degree.
She was one of the finest of Australian poets. A good poet can make the
most of the precious gift of human consciousness. A poet can sometimes
see familiar things in new combinations. A cadence of words, like music,
can play upon an idea. And then there is the special insight.
One of my favorite poems of Oodgeroo is The Past:.
Let no one say the past is dead.
The past is all about us and within.
Haunted by tribal memories, I know
This little now, this accidental present
Is not the all of me, whose long making
Is so much of the past.'
The past is indeed within us. We bear in this generation, and project
into the next, the genetic messages which we carry within us. In this es-
say, I wish to examine the scientific advances in molecular biology, which
probably comprise the most important scientific advances of this scientific
century. I refer to the unravelling of our genetic inheritance, laid down in
the deoxyribonucleic acid (DNA) found in the nucleus of each cell of our
bodies. I want to describe once again the discovery of the double helix,
which occurred forty years ago. I will sketch the consequences of this
discovery, including the establishment of the Human Genome Project,
which aims to map and describe the structure, and to discover the func-
tions, of all the genes of the human body, approximately 100,000 of them.
Hardly a month goes by without the announcement of important dis-
coveries concerning the operation of genes upon human disorders. I will
describe some of the ethical and legal problems which genomic research
is presenting. I will examine the advances being made, both in the scien-
tific aspects of genomic research and in the ethical and legal responses to
it.
My authority to write on these subjects is quite modest. As chairman
of the Australian Law Reform Commission in the 1970s and 1980s, I was
involved in a number of the early projects of that Commission which
were concerned with the interface of scientific developments and the law.
The work of that Commission on human tissue transplants law' found
expression in legislation on that topic, adopted throughout Australia. It
also illustrated how complex and controversial scientific developments
may be submitted, through public scrutiny, to informed law-making.
1. K Walker, "The Past" in The Dawn is at Hand, Jacaranda, Brisbane, 1966, 25.
2. Australian Law Reform Commission, Human Tissue Transplants, ALRC 7, AGPS,
Canberra, 1976.
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Perhaps because of this work in the Australian Law Reform Commis-
sion, I became involved in a number of international agencies relevant to
the subject matter of this essay. In the Organisation for Economic Coop-
eration and Development (OECD), I chaired two committees concerned
with the social implications of informatics-the marriage of computers
and telecommunications. In the World Health Organisation, I was ap-
pointed to the Global Commission on AIDS (Acquired Immune Defi-
ciency Syndrome). This latter post brought me into contact with some of
the foremost biological scientists, working against the clock to isolate the
viral causes of this devastating pandemic, and to present options for treat-
ment and vaccines to arrest its spread. In the International -Commission
of Jurists, where I am chairman of the Executive Committee, the future
agenda for human rights on our planet has been expanded to include the
implications for human rights of genetic engineering and the human
rights consequences of the Human Genome Project.
We have reached a point in human history where it is difficult, even for
educated and intelligent people, to know or keep in their minds the vast
sum of information about science. But of most difficulty is to see scien-
tific developments in their relations with each other and with ourselves.
In his recent book Dreams of a Final Theory, Nobel laureate Steven
Weinberg continues his search for the fundamental laws of nature, and
predicts that we are in sight of a solution described as "a theory of every-
thing." The author believes that this may be based on the suggestion that
everything is built of "strings," "tiny rips," or "glitches in space-time."
Weinberg denies the charge levelled at him by the evolutionist, Ernst
Mayr that he is "an uncompromising reductionist." Instead, Weinberg ac-
cepts the description that he is a "compromising reductionist."3
On the more humble human plane, it is important to relate the devel-
opments of informatics and genetics to one another. They come together,
on a global scale, in the Human Genome Project. My eyes were opened
to the importance of this enterprise by attending that May, 1993, BBV
Foundation conference in Bilbao, Spain.
In order to ground the legal reflections in solid data, the conference
was equally composed of distinguished scientists and lawyers from
around the globe. Four of the scientists had been honoured with the
Nobel Prize for their work. Several Nobel aspirants were in the audience
as well. In the presence of so many fine intellects, many at the cutting
3. S Weinberg, Dreams of a Final Theory, in The Australian Weekend Review, 31 July
The Human Genome Project
edges of research of such importance to our species and beyond, it was
difficult not to feel humble. But as I sat there and observed the advances
of science described one after another, my mind turned with an increas-
ing sense of anxiety to the ethical and legal questions posed. What are we
doing to address those questions?
The same question is posed to the scientist and to the laity-what do
you know about this and what are you doing about it? Is there to be a
contribution from a country such as Australia? Or are we simply bound
to the chariots of the big scientific players: doomed to pay for their re-
search for the future and hostage to their decisions on the ethical and
legal questions their research uncovers? These are, I suggest, important
questions.
III. THE DOUBLE HELIX FORTY YEARS ON
One reason for reflection is the anniversary of Watson and Crick's
breakthrough discovery of the double helix. For a stimulating essay on
that discovery, consider that of Gunther Stent, published in the New Sci-
entist.4 It is a fascinating story of how, in science, each generation stands
on the shoulders of its predecessors. Stent told of how he and the young
James Watson were sent by Max Delbriick to Copenhagen to work on the
chemistry of DNA. At that time, the existence of DNA had been known
for more than eighty years. Delbruick conceived the idea that DNA might
bear relation to how genetic messages were passed for replication from
one generation to the next. The scientist, Kalckar, with whom Stent and
Watson were to work, was specializing in a nucleotide which had nothing
to do with DNA. By chance, a visitor to the Danish Royal Society ap-
peared soon after Stent and Watson arrived at Kalckar's laboratory. The
visitor was Lawrence Bragg who, with his father William Bragg, had in-
vented X-ray crystallography and made Britain the original home of mo-
lecular structures in biology.
In 1951, in California, Linus Pauling, drawing on Bragg's work, deter-
mined that proteins in DNA contained helical structures. Pauling relied
largely on guess-work and model building rather than on conventional
crystallography. But his thesis sparked many new ideas, including those
in the mind of the young Watson sitting in Lawrence Bragg's lecture in
Copenhagen. Being the generous person that he was, Bragg threw away
his own lecture notes. He devoted his talk to a tribute of Pauling's then
unpublished discovery. Watson told Stent as he left Bragg's lecture that
4. New Scientist, (ANZ ed) 24 April 1993, 21.
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he was going to try to work out the three dimensional structure of DNA
and, in reaction to this, Stent recalls:
I thought he had lost his wits: How was he, knowing even less
about X-ray crystallography than I, going to find the structure of
DNA.
The rest is history. Watson went to Cambridge University and mas-
tered X-ray crystallography. There he met Francis Crick, a Ph.D. student
who had also conceived that it was likely the three dimensional structure
of DNA would provide insights into the nature of the gene. These two
young scientists collaborated. In the April, 1953, issue of Nature they
brought together the hitherto separate schools of informationists and
structurists, giving the offspring the name "molecular biology." This was
a watershed for science in our century-perhaps the most important. Bi-
ologists, who were interested in the mechanisms of heredity, quickly per-
ceived that the time had come to think about genetics in terms of
molecules carrying crucial information-the vital codes of human variety.
Stent, in his article, rejects the critics. He describes as "fabulous intui-
tion" the insight which Watson and Crick brought to the formulation of
the central dogma which, he says, "ranks with the Darwinian theory of
evolution as one of the few successful achievements of theoretical biol-
ogy."6 Sir Peter Medewar, in his review of Watson's book The Double
Helix said:
The great thing about [their] discovery was its completeness, its
finality .... If Watson and Crick had been seen groping towards
an answer ... if the solution had come out piecemeal instead of
in a blaze of understanding, then it still would have been a great
episode in biological history.
But it would not, concludes Stent, have been the dazzling achievement
that in fact it was.7
It took a couple of decades for the industrial and financial potential of
Watson and Crick's discovery to begin to be realized.' We are still at an
early phase of that development. There have been sad failures, as with
the millions of dollars testing sCD4 in patients with HIV (Human Immu-
nodeficiency Virus). There have been spectacular flops, as with the
monoclonal antibody known as centoxin-a hope for a magic bullet for
5. Ibid, 22.
6. Id, 23.
7. Id.
8. A Coghlan, "Engineering the Therapies of Tomorrow" in New Scientist, 24 April
1993.
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treatment of septic shock. But the journey to identify genetic causes of
human conditions and disorders would never again be the same.9 The
economic potential, and the smell of big money, began to attract similarly
big investment. The process of heredity, which has mystified humans for
millennia, had begun to unravel.
It was in this context that the Human Genome Project was conceived.
Its global nature was what first caught my attention. Here, after all, is a
scientific development affecting the human and other species, and thus
the entire planet. The urgency of finding international means of address-
ing the problems presented by information technology and nuclear fission
takes on an even greater priority when we are talking of the basic mecha-
nisms of genetic information.
A great feature of the age in which we are living is the process of in-
ternationalisation which has accompanied, and been stimulated and facili-
tated by, this scientific century. We see it in the primitive machinery of
world government provided by the United Nations and other interna-
tional and regional bodies.'0 We see it in the development of interna-
tional human rights principles which increasingly influence our domestic
laws." We see it in the global concern about the world's environment
and in international efforts to contain the explosion of the human popula-
tion, which presents such a threat to that environment.'" We see it in the
response to the AIDS epidemic.
With the unravelling of DNA's double helix, biologists were no longer
mere onlookers, reporters, and curious chroniclers of the tale of biology.
Now, they could identify, and even seek to alter or manipulate, what they
found. It was this potential of alteration and manipulation-having un-
predictable consequences for future generations of the species-which
presented the most acute ethical and legal problems still to be answered.
Coinciding with the propulsion toward modification and manipulation
came the global initiative of cartography-with the bold objective to map
the human genome. From this was born the Human Genome Project.
The time has come to describe what it is.
IV. THE HUMAN GENOME PROJECT
The Human Genome Project was launched in 1988. It is a coordinated
9. Id, 30.
10. See e.g. Mabo v Queensland (1992) 175 CLR 1, 44.
11. See e.g. Australian Capital Television Pty Limited v The Commonwealth [No 2]
(1992) 177 CLR 106 (H); Nationwide News Pty Limited v Wills (1992) 177 CLR 1 (HC).
12. A Gore, Earth in the Balance, Earthscan, London, 1992.
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world-wide research effort to determine the location of the estimated
100,000 human genes, as well as a large part of the intervening sequences.
It is the largest concerted biological project ever attempted. It has at-
tracted multi-million dollar funding. It has also attracted extensive criti-
cism in the scientific community, not the least because of its emphasis on
ascertaining the structure of the entire human genome. Some critics as-
sess that it would be preferable to spend the limited funds available to
determine the complete structure and function of individual genes of
medical importance.
The daunting scope of the project can be seen in the following data.
Here we are plunging down from the stars and the human exploration of
other worlds into the infinitesimally tiny basic life forms that exist in each
living creature. Almost all human cells, except red blood cells, contain
genetic information about the person's entire being. Each carries an
identifiable set of the body's genes estimated, as I have said, at up to
100,000. Only the egg and sperm cells ("germ cells") are different in that
they carry only one copy of each gene on twenty-three single
chromosomes.
The genes are contained in the DNA present in these cells. The DNA
is the basic bearer of the genetic information contained in the body.
Visually conceived, DNA looks like a spiral ladder. The DNA contained
in each cell would be about 2.7 meters long if unravelled. The DNA is
composed, in part, of four chemical sub-units called bases. These bases
normally pair with one another in predictable ways. The pairing of these
bases gives the DNA its "double helix" structure described by Watson
and Crick. Some genes may contain relatively few base pairs (e.g., only a
few thousand). Other genes may consist of over a million. In total,
human DNA contains about 3.3 billion base pairs. The 3.3 billion base
pairs do not just make up the genes, but a great deal of non-coding DNA
as well. The entire set of genetic material (i.e., the 3.3 billion base pairs
making up about 100,000 genes) is called the human genome.' 3 The
Human Genome Project has accepted the daunting task of mapping, or
locating the gene, and sequencing, or identifying the code of, all of this
genetic material. Because of the vast number of components of the
human genome, it is virtually inconceivable that it could possibly have
been mapped and sequenced before the advent of informatics, computers
linked by telecommunications.
13. D F Callen, "The Human Genome Project - Australian Scientists Must be In-
volved" (Opinion) in Search, vol 23, no 9, October 1992, 264.
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Some writers have likened the mapping of the human genome to ear-
lier censuses and inventories in less complex times. One participant at
the May, 1993, Bilbao conference described it as the Domesday Book of
the Twenty-first Century: the most complete inventory of humanity.
14
Other Spanish participants drew analogies between the early Iberian
maps of the world, consequent upon the journeys of Vasco de Gama and
Columbus. Here was to be a map of a vastly more complex, though invis-
ibly small, and unknown world. Yet, it is part of the living world which
we inhabit. Its cartography is just as important as that of the early global
explorers.
So far, two international bodies have been involved to a high degree in
the Human Genome Project. Most closely engaged is HUGO, the
Human Genome Organisation established in 1989 in Geneva, Switzer-
land. It has no formal decision-making powers, but its -recommendations
carry moral weight. It is a consultative and coordinating arrangement,
not between governments or institutions, but between people involved in
the Project. It describes itself as an "enabler" rather than a "provider" or
rule-maker. HUGO does not fund research, judge its results, or have any
financial control. Nor does HUGO judge or arbitrate on ethical issues. It
simply creates networks and channels, of information to assist the flow of
data. It promotes global cooperation and the idea of mutual benefit. It is
a non-profit making organisation. In legal terms, it is a non-government
organisation appointed by its participants. It derives its legitimacy from
the status of those leading scientists involved in it. HUGO's system of
election ensures that only scientists of high standing are admitted to its
ranks.i 1
When HUGO was established, it was contemplated that the Human
Genome Project would be completed in about twenty years, by the year
2005. Whether this will be so, and whether the functions of the primary
body of the Human Genome Project will be complete by that time, re-
mains to be seen. The project is apparently well on schedule, and possi-
bly even ahead of schedule. The first five years have been spent mapping
the genes and developing technologies to increase the speed and decrease
the cost of sequencing. The remainder of the project is to be spent se-
quencing. Chromosome 21 and the Y chromosome have already been
completely mapped, and mapping the others is well underway.
14. F W Hondius, "Man's Freedom and the- Human Genome" in Papers of the Interna-
tional Workshop Human Genome Project: Legal Aspects, Fundacion BBV, Bilbao, 24-26
May 1993, to be reproduced in the Papers of the Conference.
15. Ibid, 9f.
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The other international body which has been involved in consideration
of genomic research is UNESCO (United Nations Educational, Social,
and Cultural Organisation) located in Paris, France. Its activities have
been relatively limited, although they have stimulated regional and na-
tional explorations of the ethical and legal issues. A member of the
UNESCO committee, Professor Santiago Grisolia, was the proponent of
all three BBV Foundation conferences in Spain.
Most of the work relevant to the Human Genome Project is taking
place in the United States. The U.S. government has, over the past five
years, actively encouraged close ties between industry, research scientists,
and the medical community in the Project. Furthermore, significant
funding has been provided by the U.S. government for the Human Gen-
ome Project. For example, the 1992 U.S. budget allocated no less than
154 million dollars to be shared with the National Institutes of Health
(NIH) and the Department of Energy. The United Kingdom has also
committed fifteen million pounds over the three years from 1989 to 1992.
Several European countries have likewise devoted specific government
funds to the project. Canada has allocated eighteen million dollars over
the next five years.
In my own country, Australia, there is no specific funding for the
Human Genome Project. It does not even rank a mention as a "special
initiative area" in the report of the Australian National Health and Medi-
cal Research Council. That Council allocated a one-off grant of 100,000
Australian dollars over two years to HUGO. But in Australia, our contri-
bution to the Project basically comes from the work being performed at
the Department of Cytogenetics and Molecular Genetics at the Adelaide
Children's Hospital (on chromosome 16), and the establishment of the
Australian National Genome Information Service (ANGIS) within Syd-
ney University.
The work in Adelaide, the home town of Professor Somerville, under
Dr. Grant Sutherland, is actually funded from the United States by the
Department of Energy. Its aim is to break up the 100 million base pairs
of DNA present in chromosome 16 into small manageable pieces. The
Adelaide contribution involves the construction of a high resolution phys-
ical map of the chromosome by incorporating different segments of chro-
mosome 16 into mouse/human somatic cell hybrids. The hope is that, by
the use of markers, it will be possible to isolate the DNAoof any region of
particular interest.
Such research is not of purely theoretical concern. For example, Bat-
The Human Genome Project
ten's Disease, a neurological degenerative disease of children which is
prone to juvenile onset, has been mapped to chromosome 16. An inter-
national collaborative effort, directed from London, links studies of chil-
dren in many countries who present with this insidious disease. Work is
now underway, including in Adelaide, Australia, in the hope of isolating
and identifying the gene which is involved in the presence of Batten's
Disease. Obviously, its identification will have implications for future
treatment and possible future genetic manipulation to remove the offend-
ing gene (including from progeny) and prevention (including by antenatal
screening and termination of pregnancies where the offending gene
appears). 6
When the Human Genome Project was instituted, it was hoped that the
genetic developments would be accompanied by new information tech-
nology which would allow the faster sequencing of the vast array of DNA
components in the human genome. Although there have been significant
improvements in the information technology, the radical breakthroughs
that were expected have yet to occur. They rarely arrive on time-and on
demand. This has led to some shift of attention in recent times toward
select sequencing of the coding of genes that represent only five percent
of the total amount of DNA.
One of the most hotly contested developments which has occurred dur-
ing the life of the Human Genome Project has been the initiative of the
NIH to attempt to patent randomly isolated partial gene sequences of
unknown function. Concern about this development, which appears to
undermine the principle of international cooperation that is at the heart
of the Human Genome Project, divided participants of the May, 1993,
Bilbao conference. It led to many an angry clash there, as it has done
earlier in other parts of the world.
V. TIE PROMISE Is GREAT
Media watchers will be aware of many reports which laud the potenti-
ality of research on the human genes: to identify the causes of human
disorders as the first step toward their prevention or cure.
Thus, in March, 1993, the Australian journal, The Bulletin,'7 described
the advances in genetic diagnosis. Genetically inherited or determined
disorders-such as cystic fibrosis, Tay-Sachs Disease, Down Syndrome,
and Thalassaemia-were shown to derive from specific genes. They can
16. The Adelaide project is described in Callen, above n 13, 265.
17. 2 March 1993, 40.
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be identified genetically before they manifest themselves physically. At
present, the major application of genetic diagnosis of this kind is to per-
mit termination before birth, either by embryo wastage (if in vitro fer-
tilisation [IVF] is involved), or by abortion, in the aspiration of "better
luck next time." But for the future, beyond such screening, the hope
beckons that intervention may prevent the physical manifestation of the
particular gene and its communication through the germ line to future
generations.
Among the work performed by Dr. Sutherland's unit in Adelaide has
been that which has helped to locate a gene responsible for the second
most common cause of mental retardation, called Fragile X syndrome.
So far, it is not known how the Fragile X gene causes the retardation;
only that it does.'"
There have also been announcements of the discovery of the genes re-
sponsible for Huntington's chorea and amyotrophic lateral sclerosis. At
the same time came the claim that the gene responsible for colon cancer,
which kills at least 300,000 persons each year and is the second leading
cause of cancer death in the United States, had been isolated.' 9 Accord-
ing to the commentators, if a person presents with the marker detected in
a simple blood test there is a better than ninety-five percent chance that
he or she will develop the cancer. Colon cancer is susceptible to early,
but not later, surgical treatment. Early diagnosis may help early interven-
tion and the saving of lives.
With much media attention came the suggestion that scientists would
soon be able to pinpoint the genes responsible for height, weight, intelli-
gence, skin pigmentation, and other non-disease traits. This news
prompted anxious questions about the potential for misuse of character
traits deemed "unattractive or not useful." It is important at this stage to
distinguish between scientific fact, for example, the identification of the
Alzheimer's gene, and media hype, such as the alleged discovery of a
supposed "gay" gene. An Australian editorial projected the frightening
possibility that the discoveries of the Human Genome Project might lead
to the Nazi-style eradication of individuals who were, for example, homo-
sexuals. The editor remarked:
If [homosexuality] were genetically inherited, no blame could
attach, and laws made to punish offenders for their sexual pref-
erence or practices would be insupportable. On the other hand,
18. Deborah Smith, "The Gene Hunters", Sydney Morning Herald, 13 April 1993, 11.
19. Newsweek, 11 May 1993, 76.
The Human Genome Project
opponents of decriminalization of homosexuality might propose
genetic correction in place of the failed diversion therapies of
the past that relied on the belief that homosexuality was a be-
havioral problem.2°
This subject was taken up at the same time by the Jewish press in Eng-
land. Lord Jakobovits, former Chief Rabbi of the British Common-
wealth, was reported as saying:
If we could[,] by some form of genetic engineering[,] eliminate
those [homosexual] trends we should-so long as it is done for a
therapeutic purpose.2'
This comment evinced strongly antagonistic responses from the Union of
Jewish Students in Britain:
As Jews we find the idea of using genetic engineering to elimi-
nate homosexuality an affront to human rights and dignity. It is
disturbing to find Jews advocating something akin to that prac-
ticed against our people by the Third Reich.22
The Economist has reported the work of scientists in Pennsylvania on
the identification of the genetic trigger for Kennedy's Disease-a degen-
eration of the nerves affecting muscles and another cause of mental retar-
dation.23 Also in September came the news from Duke University of a
claim that scientists had discovered a gene likely to cause the develop-
ment of late onset Alzheimer's disease.24
In Australia there was coverage of the opening of a Broadway play on
genetic selection. A Jewish family, by prenatal screening, discovered that
the foetus carries a genetic structure considered typical to homosexuals.
The mother's brother, himself gay, is outraged when he learns that his
sister might abort the child. The author, Jonathan Tolins, puts these
words into his mouth:
What if you found out the kid was going to be ugly, or smell bad,
or have an annoying laugh? Where do we stop? You know we
have relatives who died for less. Now that we have this technol-
ogy, what are we going to do with it?
What indeed! These are the questions which have confronted many
ethicists and lawyers. They were at the forefront of the May, 1993, Bilbao
conference.
20. 5 August 1993, 10.
21. In a letter to the Jewish Chronicle, July 1993.
22. Quoted in the Sun Herald, (Sydney) 1 August 1993, 10.
23. The Economist, 28 August 1993, 72.
24. Sydney Morning Herald, 10 September 1993, 4.
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VI. THE PROBLEMS OF GENOMIC INSIGHT
The basic problem of genomic insight was stated by James Watson him-
self at the 1990 BBV Foundation meeting in Bilbao, Spain, which ex-
amined the ethical quandaries. There, Watson said:
[G]enetic injustice arise[s] through throws of the genetic dice
that operate when our sperm and egg are formed. This genetic
variability between humans reflects the fact that the gene distri-
bution process is not perfect and the new genetic mutations are
constantly arising. There is no way to stop this process. More-
over, the variation has been the basis of our evolution. Without
the differential of survival of more fit variants, we as human be-
ings would not have our highly empowered brains that have led
us to develop the languages.., that underlie the creation of our
various civilizations. The question now faces us... as to how we
are going to deal with these differences between individuals. In
the past, at the time of the eugenics movement ... and during
the reign of racist thoughts in Nazi Germany, there was very
little genetic knowledge. Most decisions were made without
solid genetic evidence .... Now we have to face the fact that we
soon will have real facts and how are we going to respond to
them?25
Some speakers at the May, 1993, Bilbao meeting answered this ques-
tion by expressihg a deep sense of anxiety about the implications of geno-
mic research for human freedom. Thus, concern was expressed about the
way in which the Human Genome Project itself has been initiated and
funded by governments and scientists with very little input from the pub-
lic. Dr. Frits Hondius of the Netherlands said:
We expect that those who fund, administer and execute the
Human Genome Project should make every effort to close the
information gap between the genome scientists and the general
public. If any survey or poll was carried out within a random
section of the population with the following question: Have you
ever heard of the Human Genome Project? I am afraid that, as
matters stand now, the result will be zero.26
The result would be no different in the United States or Australia. Yet,
it is impossible to see the introduction of human ethical values, reflected
in human laws, if the community is basically unaware of-and indifferent
to-what is going on and uninformed about its social implications.
25. J Watson, in Fundacion BBV, Human Genome Project: Ethics, 1990, Madrid, 27.
26. Hondius, above n 14, 4.
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That same thoughtful commentator questioned the implications of the
Human Genome Project for the very rule of law upon which our societies
are ostensibly based. If there is no law that effectively governs genomic
research and development and if, notwithstanding this fact, such research
and development has crucial potential for the future of the species, an
astonishing gap is revealed which we should hasten to fill in close har-
mony with an informed community. In Europe, an Intergovernmental
Steering Committee on Bioeihics within the Council of Europe has been
developing a Bioethics Convention. Representatives of a number of
countries, including the United States, Australia, Canada, and Japan,
have been observing this process. It may have implications far beyond
Europe. The foundation of the convention includes respect for basic
human rights: for the dignity of each human being in all stages of biologi-
cal development. It also includes prohibition of applications of biological
research, contrary to the fundamental values of humankind. Perhaps
more controversially, the European Convention includes provisions that
guarantee equitable access to the benefits of biomedical sciences, prohibi-
tion of treating the human body, or parts of it, as a commercial commod-
ity, and respect for the autonomy of persons undergoing medical
treatment which involves genetic testing, counselling, and confidentiality
of genetic data.27
Often unstated, but in the minds of every lawyer and most citizens who
consider a development such as genetic research, is the horrible aberra-
tion that occurred in the Nazi death camps, purportedly in the name of
scientific experimentation.' These led to the trials at Nfiremberg in 1947
of many of those involved. They also led to the acceptance, by the inter-
national community, that human beings should not be used for medical
experiments without free consent and proper conditions. Drawing the
line between research and experimentation, and crossing the line from
discovery into action present acute ethical problems upon some of which
each society would wish to establish its own binding rules.
It is here that the work of Law Reform Commissions, and other like
work, provides a model which should be kept in mind. By consulting the
experts and informing and consulting the community in all parts of the
country, laws were developed which squarely presented Parliaments with
options for action. A high measure of uniformity was secured in the laws
27. Ibid, 11.
28. G Annas and M A Grodin, The Nazi Doctors and the Nuremburg Code, OUP,
New York, 1992.
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on human tissue transplants. Upon some issues the legislatures in differ-
ent parts of Australia chose different options. Yet at least the hard ques-
tions were faced and answers were given by the democratic branches of
government which were accountable to the people.
The alternatives to these procedures will be that judges of the common
law, doing their best upon materials presented by individual litigants, will
provide the answers, or the law will offer no answers and then scientists
will rush on without any relevant legal constraints.
Among the specific topics examined in Bilbao were the following im-
plications of genomic research:
* The right to confidentiality in the use of an individual's ge-
netic information;
" The implications- of genetic, research for the culpability of
criminal offenders;
" The developments of the law of patents and intellectual prop-
erty for the protection of the investment of research and in-
dustrial organisations;
" The implications of genetic research for insurance and spread-
ing the risks within society of genetic defects;
* The imposition of legal limits on genetic experimentation.
deemed bizarre or unacceptable to the human community;
" The identification of human beings by.genetic testing and the
legal aspects of using the genetic identity as a unique and uni-
versal human identifier, and;
* The implications of knowledge about workers' genetic condi-
tions in the labor market.
The right to confidentiality presents the paradox of detailed human
gene mapping at the very time of heightened demand for respect for indi-
vidual privacy. The reconciliation of greater knowledge about the indi-
vidual with demands for respect for the individual's control over his or
her own information obviously requires much legal attention.29 The risk
of genetic discrimination was raised by several participants of the confer-
ence. It was pointed out that many individuals would not wish to know
their own genetic information. Still fewer would wish. to have it known
by others without strong reasons, individual consent, or express authority
of law giving consent in terms compatible with the ideals of a democratic
society.
The session on criminal culpability explored the age-old problem of
free will. If it were shown that, even to some extent, violence was the
29. Canada, Privacy Commissioner, Genetic Testing and Privacy, 1992.
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product of genetic inheritance, would it be just for the legal system to
hold the subject personally responsible under the criminal law? Our
criminal law operates upon assumptions of individual responsibility for
behavior causing harm to others. But what if it were shown that certain
individuals had genetic predispositions which could be proved by geno-
mic research? Would this be a basis for an excuse for the individual con-
cerned who had simply acted out his or her genomic messages? Or
should the law persist, in the face of such discoveries, with the insistence
that every individual is criminally responsible for conduct that adversely
affects others in society?
The implications of patent law for genomic research stirred the greatest
emotions. A leading United States scientist, Dr. Craig Venter, pointed
out that over 35,000 applications for patents of biological material had
already been lodged in the United States compared with approximately
13,000 in Europe. It should be noted that, at the time of the meeting,
none of Dr. Venter's applications was successful. The main apparent rea-
son for the delay is that the sequences were still of unknown function.
Despite this, several speakers suggested that intellectual property law was
not keeping pace with the nature of the problem presented by genomic
research. What was needed was a new concept which afforded a measure
of protection for the investments of the researchers but offered protec-
tion for a shorter period and under different conditions. Those conditions
would need to be more apt to the sharing of the beneficial advances in
human genomic research so that, affecting the whole human species, they
would be available on a global scale, and- not just confined to benefit
humans in the developed world.
A participant from Argentina captured the mood of many delegates.
He pointed out that James Watson himself had refused to patent his ma-
jor discovery of the double helix. Watson had said that it should be avail-
able for all humanity. The attempted patenting of human life forms was,
in this participant's eyes, "completely immoral." The human species and
its genes did not belong to American corporations. This -point was taken
up by a distinguished professor from the famous Johns Hopkins Univer-
sity. He deplored the commercialization of university research and re-
garded it as very short-sighted. These themes were developed by many
participants from the floor. Some described the patenting of the products
of human genomic research as a new form of "neo-colonialism" which
would result in gross delays in the spread of scientific knowledge relevant
to medicine and the curing of disease to the people of the world, espe-
cially in developing countries.
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The session on insurance at the conference examined the limits, if any,
that should be placed on the use of genomic information by insurance
companies. Insurance is a means of spreading the risk of disease and
premature death amongst the policy holders. If a person suffers from an
irrevocable condition, discoverable in the genes, should that not simply
be accepted as part of the human variety covered by risk bearing insur-
ance? Yet if insurers, to minimize their risk, can test proponents for heart
conditions and can exclude smokers or others who enhance the risk of
disease and death, why should they be forbidden from having access to
wholly accurate and precise data which shows the presence of genetic
conditions likely to affect a person's health and life expectancy? Con-
cerning actuarial risk, the facility of precise identification of risk would
afford insurers, unless checked by law, with more scientific data upon
which to judge the acceptance of insurance and the fixing of premiums to
spread risks among their insured. 0
The limits on genetic experimentation require consideration of the var-
ious forms of regulation that could be invoked in this connection. These
limits include criminal law, internal control in research institutes, peer
review and individual self-regulation."' A recurring theme in most of the
academic commentary on the Human Genome Project is the need for
community involvement. A recurring complaint is the relative lack of
community participation until now.
Perhaps it is on that footing that legislation has been proposed in
France to control at least some of the developments of genomic research
that are considered unacceptable. The French legislation contains provi-
sions which would, if enacted:
* Ban arrangements for surrogate motherhood with criminal
penalties for intermediaries, although not for the pregnant
women involved;
" Strictly limit in vitro fertilisation to heterosexual couples with
fertility problems;
" Maintain permanently the anonymity of the donors of sperm
and egg in cases of artificial insemination donor;
* Outlaw the sale of organs, tissue, and blood;
* Forbid the manipulation of genes, except to improve the
30. United States, Report of the Task Force on Genetic Information and Insurance,
May 1993.
31. P M McNeill, The Ethics and Politics of Human Experimentation, Cambridge,
1993. See also L Darvall, Medicine, Law and Social Change, Dartmouth, Aldershot, 1993.
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health of a particular patient and then sanction any interfer-
ence with the patient's germ line;
" Restrict the provision of information from genetic tests, pre-
cluding its use by employers to screen job applicants or by
insurance companies to assign risk categories; and
" Forbid patenting of human genes.32
Every one of these provisions would be highly controversial. For my
own part, I would want to confine or modify, every one of them. But at
least the French legislature3 3 has begun to address these issues. The
Council of Europe, as I have said, is developing a regional convention.
But in most parts of the world, these issues have been largely ignored,
while politicians indulge themselves in the bread and circuses that occa-
sion the deep cynicism which infects Western democracies at the very mo-
ment of the triumph of the liberal state.
The Bilbao Declaration was adopted at the close of the May, 1993,
meeting which I have been describing. In ringing tones, it asserted that
genetic variations, like social diversity, constitute attributes of free human
beings. The idea of a monochrome genetic "perfection" and of eliminat-
ing the precious variety of humanity by genetic means was declared to be
socially repulsive. The great Spanish painter, Goya, like Beethoven, be-
came deaf; Milton became blind; Mahler died of a congenital heart com-
plaint; and each one of us carries genetic features that add to the
diversity, of humanity. The greatest care is needed now as we face the
possibility of reducing, or even eliminating, elements of this diversity.
Most of us would understand, even if we would not agree with, a deci-
sion, conscientiously taken, to terminate a pregnancy upon the discovery,
by genetic testing, of the presence of Down Syndrome or the Fragile X
gene. But where then is the line to be drawn? For gender selection? To
exclude homosexuals? To favor the tall, the blonde, or the beautiful? To
preselect skin pigmentation, eye colour, or intelligence? To exclude a
propensity to obesity or a potential for ugliness? Even more perplexing
is the question of interference in the human germ line with the risk of
sending into new generations manipulated genes which may banish par-
ticular inherited conditions with consequences as yet unforeseen.
Do not think that this is purely hypothetical talk. One of the Nobel
laureates in Bilbao was Dr. Carleton Gajdusek. He co-discovered the
Kuru's Disease in New Guinea, a viral condition sometimes transmitted
32. R Herman, "France Defines the Ethics of High-Tech Medicine", Washington Post
Health Report, 20 October 1992.
33. Ibid.
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through cannibalism. Now, a new variant of this condition has appeared
in those patients treated decades ago for dwarfism by the use of human
pancreatic product secured mostly from coroner's cadavers. In the busi-
ness of genetics, we lay down problems for the future. The clock ticks
away. The alarm bells may one day ring, even unto the future
generations.
VII. CONCLUSIONS AND A CALL TO ACTION
The Human Genome Project presents both promise and problems, as I
hope I have demonstrated. It is not a choice of one or the other. With
the one comes the other.
It is essential, both nationally and internationally, that scientists should
speak to ethicists and to lawyers and to citizens. There is a need for
multi-disciplinary involvement as the Human Genome Project progresses
and as its consequences are presented. This is one area where lawyers
and ethicists in Australia have some techniques to export. We refined
them in the Law Reform Commission. They remain as valid today. They
present the means of confronting bioethical questions which will other-
wise be consigned to the "too hard" drawer. They ensure that the ac-
countable, democratic branches of government face up to the truly
challenging issues of our time. They reinforce the rule of law. They help
to respond effectively to the new challenges to human rights which geno-
mic research presents. All countries will need to look to the legal impli-
cations presented by human genetic research and the technology that
follows it. At least the United States and Australia should begin prepar-
ing for the legal issues raised by human genomic research and associated
developments. There is now the French legal model. There is also now a
German law. Countries which cannot always export scientific research,
or contributions worth talking about, to the Human Genome Project it-
self, can perhaps export a serious legal reflection upon the basic rules
which should govern a common law country in its approach to the
problems that are present, and will be present, as a result of genomic
developments.
It is vital that the human brain which has conceived, perceived, and
then described DNA, the double helix, and the basic forms of life, should
have the wisdom to construct rational rules for the global conduct of ge-
netic research, experimentation, and manipulation. Not to do so is to
make a decision. Let there be no doubt of that. And it is a decision
which has a potential to affect the future of our species. Indeed it may
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affect the very shape and form of our species, even whether our species
takes itself by these miraculous discoveries into a new and different form.
Truly then humanity, like Prometheus, will have defied the Gods, stolen
the fire of creation, and given it to humans.34 Let us hope that we have
the courage to change that which needs changing in members of our spe-
cies, by the brilliance of our discoveries; the strength to hold back from
disturbance of the marvelous variety of humanity which is our genetic
legacy; and the wisdom to know the difference between the occasions for
change and for restraint.
I close as I began, with Oodgeroo's timeless words. They describe the
island continent in which Margaret Somerville and I grew up as children
and received the privilege of our university training. They capture Aus-
tralia's vast distances and the spirit of its indigenous people. In that
spirit, and in the words of one of our great poets, is a reminder of the
power of genetics. It marks us off as individuals. But it also binds us
together as members of the human family:
No walls about me
The stars over me
The tall surrounding trees that stir the wind
Making their own music,
Soft cries of the night coming to us, there
Where we are one with all old Nature's lives
Known and unknown ...
.... A thousand thousand camp fires in the forest
Are in my blood
Let no one tell me the past is wholly gone.
Now is so small a part of time, so small a part
Of all the race years that have moulded me. 35
34. M Charlesworth, Life, Death, Genes and Ethics, ABC Boyer Lectures 1989, Syd-
ney, 25.
35. See n 1 above.
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